To hear about similar clinical trials, please enter your email below
Trial Title:
Financial Navigation Study Among Young Adult Blood Cancer Survivors
NCT ID:
NCT05620979
Condition:
Survivorship
Cancer
Financial Stress
Conditions: Official terms:
Hematologic Neoplasms
Financial Stress
Study type:
Interventional
Study phase:
N/A
Overall status:
Active, not recruiting
Study design:
Allocation:
Randomized
Intervention model:
Single Group Assignment
Intervention model description:
This is a multi-site, three-arm, financial navigation intervention
Primary purpose:
Health Services Research
Masking:
None (Open Label)
Masking description:
no blinding
Intervention:
Intervention type:
Behavioral
Intervention name:
Providing financial navigation via active navigation, ad hoc navigation or no study-based navigation.
Description:
Providing financial navigation to blood cancer survivors.
Arm group label:
Active Navigation
Arm group label:
Ad Hoc Navigation
Arm group label:
No study-based Navigation
Summary:
Young adult cancer survivors (18-39y) are at increased risk of financial distress. This
study seeks to better understand the financial challenges experienced by these
individuals via quantitative serial assessments, study-based financial navigator
encounters and an end of study qualitative interview.
Detailed description:
This fully remote, multi-site study will evaluate the role of financial navigators in
relieving financial distress in young adults (18-39y) who have completed treatment for
blood cancer at least three years ago. Serial Assessments at study entry, 3-months, and
6-months measure financial distress measured using the study's primary outcome measure
the Personal Financial Wellness Scale™ (PFW) (see below), hypothesized effect modifiers
(emotional distress, self-efficacy, cognitive functioning), as well as care seeking,
household finances and insurance characteristics. Randomization will occur following
completion of baseline measures (see below for description of study arms). In addition to
a formal evaluation of the intervention at 3- and 6-months, an optional interview will
occur following the 6-month assessment/navigation intervention period to gain further
insight from participants about the acceptability of the intervention. For ethical
considerations related to the topic of study, all participants will be provided with the
Leukemia & Lymphoma Society's information specialist hotline.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
1. Previous diagnosis and treatment of blood cancer (leukemia, lymphoma, myeloma,
myelodysplastic syndrome, or myeloproliferative neoplasm)
2. Current age between 18-39 years old
3. Blood cancer diagnosis during childhood (0-17 years of age) or young adulthood
(18-36 years of age)
4. At least three years post blood cancer diagnosis
5. Off treatment for blood cancer or on a long-term regimen with an oral anti-cancer
medication with stable disease
6. Off treatment for a second cancer (non-blood cancer) or on a stable long-term
regimen, such as hormone therapy or hormone replacement therapy
7. Primary residence in United States
8. Able to understand and read the English language
Exclusion Criteria:
- On parent or guardian's insurance
Gender:
All
Minimum age:
18 Years
Maximum age:
39 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
Children's Hospital Los Angeles
Address:
City:
Los Angeles
Zip:
90027
Country:
United States
Facility:
Name:
University of Southern California (USC Norris Comprehensive Cancer Center & LA County Hospital)
Address:
City:
Los Angeles
Zip:
90033
Country:
United States
Facility:
Name:
Tufts Medical Center
Address:
City:
Boston
Zip:
02111
Country:
United States
Facility:
Name:
Bon Secours Mercy Health System
Address:
City:
Greenville
Zip:
29607
Country:
United States
Facility:
Name:
MD Anderson
Address:
City:
Houston
Zip:
77030
Country:
United States
Start date:
February 14, 2022
Completion date:
June 30, 2024
Lead sponsor:
Agency:
Tufts Medical Center
Agency class:
Other
Collaborator:
Agency:
The Leukemia and Lymphoma Society
Agency class:
Other
Source:
Tufts Medical Center
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05620979
